Figure 1
Kaplan–Meier estimate of progression-free survival by cytogenetic risk status. CI, confidence interval; Kd, carfilzomib and dexamethasone; NE, not estimable; PFS, progression-free survival; Vd, bortezomib and dexamethasone.
Figure 1 | Leukemia
